je.st
news
Tag: to
ConAgra to Employees: About 40 IT Jobs to Be Cut in Omaha
2015-10-17 01:04:33| Food - Topix.net
ConAgra Foods has told employees it will eliminate about 40 information-technology jobs as the packaged food company looks to slash its payroll in Omaha and elsewhere. ConAgra revealed the cuts Friday morning in a memo obtained by the newspaper.
3D Systems Partners With To Bring 3D Printing To Cosmetic Surgery
2015-10-16 22:08:36| Electronics - Topix.net
Using full-color 3D printed before and after models, MirrorMe3D is able provide patients with a life-like physical representation of their potential surgical outcome. ROCK HILL, S.C., Oct. 15, 2015 -- 3D Systems announced today that MirrorMe3D , a New York-based startup, is using 3DS' end-to-end digital thread for healthcare to help deliver improved patient experiences during cosmetic surgery.
Tags: to
systems
bring
partners
Federal probe of former Chicago Schools CEO expands to Detroit
2015-10-16 20:23:00| American School & University
Investigators are looking at contracts awarded in Detroit when Barbara Byrd-Bennett was the district's chief academic and accountability auditor read more
Tags: to
schools
federal
chicago
AT&T to 'lifelong customer:' Shut up & talk to the lawyers
2015-10-16 20:05:39| Telecom - Topix.net
Send a thoughtful suggestion to AT&T's chief exec, and what do you get? A letter from the company's lawyers suggesting that you quietly go away. You don't need an MBA to know that in business, few things are more important than listening to your customers.
Medivir Announces That Janssen Has Started a Phase IIa Study to...
2015-10-16 18:07:48| Appliances - Topix.net
Medivir AB today announces that Alios BioPharma Inc., part of the Janssen Pharmaceutical Companies , has started a phase IIa clinical trial to evaluate the combination of simeprevir, odalasvir , and AL-335 in treatment-nai 1 2ve patients with genotype 1 chronic hepatitis C virus infection. This phase IIa study is a randomized, open-label, three-arm study of AL-335, a nucleotide-based HCV NS5B polymerase inhibitor, odalasvir, an HCV NS5A inhibitor and simeprevir, an HCV NS3/4A protease inhibitor.
Sites : [1108] [1109] [1110] [1111] [1112] [1113] [1114] [1115] [1116] [1117] [1118] [1119] [1120] [1121] [1122] [1123] [1124] [1125] [1126] [1127] next »